About 3613

Founded: 1669
Employees: 780
CEO: Wang Chi
WebsiteView website: cm.tongrentang.com

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments. The company also offers Chinese medical consultation and treatment services. It markets its products under the Tong Ren Tang brand name. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, the Oceania, North America, and Europe. The company was founded in 1669 and is based in Wan Chai, Hong Kong.

Recent 3613 News & Updates

Announcement • May 27

Beijing Tong Ren Tang Chinese Medicine Company Limited Receives Certificate of Registration of Proprietary Chinese Medicine

Beijing Tong Ren Tang Chinese Medicine Company Limited has received the Certificate of Registration of Proprietary Chinese Medicine issued by the Chinese Medicine Council of Hong Kong, allowing “Antelope Horn Powder Capsules (Tong Ren Tang) to be sold in the Hong Kong Special Administrative Region of the People’s Republic of China. The relevant details are as follows: Name of the medicine: Antelope Horn Powder Capsules (Tong Ren Tang). Registration number: HKC-18854. Certificate validity period: Until May 21, 2031. The function and main indications of the “Antelope Horn Powder Capsules (Tong Ren Tang)” are indicated for pacifying the liver and extinguishing wind, clearing the liver, improving vision, dissipating blood and removing toxin. It is used for internal stirring of liver wind, fright epilepsy, convulsions, pregnant epilepsy, high fever with convulsions and seizure, epilepsy, manic psychosis, headache, dizziness, red eyes and nebula, macula and papule caused by warm toxin, swelling abscess, sore and skin infections. As of the date of this announcement, the Company has cumulatively invested approximately HKD 1.83 million (unaudited) in the research and development of “Antelope Horn Powder Capsules (Tong Ren Tang)”. This product has not yet been launched for sale in the market. Upon obtaining the Certificate of Registration of Proprietary Chinese Medicine issued by the Chinese Medicine Council of Hong Kong, “Antelope Horn Powder Capsules (Tong Ren Tang)” produced by the Company can be sold in Hong Kong, which is conducive to expanding the product lines of the Company and beneficial to the market expansion of the Company. The obtaining of the aforementioned certificate of registration is not expected to have any material impact on the production, operation and performance of the Company for the time being. The sales of pharmaceutical products can be influenced by factors such as changes in the policy environment, exchange rate fluctuations and market competition in the Hong Kong region.

Recent updates

No updates

Beijing Tong Ren Tang Chinese Medicine Company Limited Stock Price

3613 Share Price Performance

3613 Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

Beijing Tong Ren Tang Chinese Medicine Company Limited Key Details

About 3613

Recent 3613 News & Updates

Upcoming dividend of HK$0.40 per share

Beijing Tong Ren Tang Chinese Medicine Company Limited Receives Certificate of Registration of Proprietary Chinese Medicine

Investors Can Find Comfort In Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Earnings Quality

Recent updates

Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors

Hansoh Pharmaceutical Group

Innovent Biologics

WuXi Biologics (Cayman)

Sichuan Kelun-Biotech Biopharmaceutical